BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allegretti AS, Parada XV, Endres P, Zhao S, Krinsky S, St Hillien SA, Kalim S, Nigwekar SU, Flood JG, Nixon A, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Regner KR, Belcher JM, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT; HRS-HARMONY study investigators. Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study. Clin Transl Gastroenterol 2021;12:e00359. [PMID: 33979307 DOI: 10.14309/ctg.0000000000000359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Jalan R, Rose CF. Heretical thoughts into Hepatic Encephalopathy. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.014] [Reference Citation Analysis]
2 Allegretti AS; HRS-HARMONY study investigators. Response to Weng. Clin Transl Gastroenterol 2021;12:e00383. [PMID: 34251360 DOI: 10.14309/ctg.0000000000000383] [Reference Citation Analysis]
3 Fang Y, Zhu H, Gao C, Gu Y, Liu Y, Yuan Y, Wu X. Value of shear wave elastography in predicting hepatorenal syndrome in patients with liver cirrhosis and ascites. Int J Clin Pract 2021;75:e14811. [PMID: 34490949 DOI: 10.1111/ijcp.14811] [Reference Citation Analysis]
4 Ma AT, Juanola A, Solà E. Assessment of kidney function in cirrhosis: Are we moving closer to accurate estimation of glomerular filtration rate? Liver Int 2022;42:957-9. [PMID: 35447007 DOI: 10.1111/liv.15238] [Reference Citation Analysis]
5 Velez JCQ. Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy. Kidney360 2022;3:382-95. [PMID: 35373127 DOI: 10.34067/KID.0006722021] [Reference Citation Analysis]
6 Miller B, Regner K, Sorokin A. p66Shc signaling does not contribute to tubular damage induced by renal ischemia-reperfusion injury in rat. Biochemical and Biophysical Research Communications 2022;603:69-74. [DOI: 10.1016/j.bbrc.2022.03.020] [Reference Citation Analysis]
7 Weng F. Comment on "Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis". Clin Transl Gastroenterol 2021;12:e00382. [PMID: 34251358 DOI: 10.14309/ctg.0000000000000382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Basthi Mohan P, Nagaraju SP, Rangaswamy D, Musunuri B, Prabhu Attur R, Bhat G, Shailesh, Shetty S. Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis. Clin Chim Acta 2021;523:339-47. [PMID: 34666028 DOI: 10.1016/j.cca.2021.10.015] [Reference Citation Analysis]
9 Solé C, Ma AT, Solà E, Carol M, Fabrellas N, Juanola A, Napoleone L, Gratacós-Ginès J, Bassegoda O, Cervera M, Pérez M, Rubio AB, Avitabile E, Morales-Ruiz M, Graupera I, Pose E, Kamath PS, Ginès P. Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome. Liver Int 2021;41:2729-32. [PMID: 34569697 DOI: 10.1111/liv.15069] [Reference Citation Analysis]
10 Khemichian S, Francoz C, Nadim MK. Advances in management of hepatorenal syndrome. Curr Opin Nephrol Hypertens 2021;30:501-6. [PMID: 34397647 DOI: 10.1097/MNH.0000000000000730] [Reference Citation Analysis]